Tunisia: A New Framework for Biotech Investments
The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th…
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for reform of the import process for pharma products in the Arab world; Hikma’s buyup of GSK assets in…
The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th…
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes…
Salim Ouertani, business unit manager at AbbVie Tunisia, has been with the affiliate since its beginning in Tunisia when it was spun-off from Abbott in 2013, being in charge of ensuring a smooth transition. Presently, AbbVie’s manager runs ethical operations and is looking forward to supporting more patients suffering from immunology diseases in Tunisia. Ouertani describes the role of AbbVie…
Fatma Thabet Chiboub, CEO of the Bizerta Economic Activities Park (PAEB) in Tunisia, explains the advantages for a company of establishing itself in the PAEB, the importance of high added-value…
Myriem Tamimy gives an overview of the ongoing situation for Janssen and pharma multinationals more generally in Morocco, discusses the next steps in the authorities’ pharma strategy and the role…
See our Cookie Privacy Policy Here